S., Perrine, S
There is a clear relationship between the thickness of the epicardial fat layer and the degree of myocardial inflammation and fibrosis.34 The epicardial fat volume is significantly greater in HFpEF patients, and many of the comorbidities associated with HFpEF, such as obesity, diabetes, and chronic kidney disease, also show epicardial fat increases.33 In HFrEF, the relationship is less clear, as both high and very low epicardial fat values have been reported in these patients.34 In addition, excess epicardial fat has been associated with a poorer prognosis in HFpEF.3335 A significant increase in any cause deaths and HF hospitalizations36 has been reported in patients with preserved or mildly reduced EF values, regardless of the body mass index and other comorbidities
A practical goal is one to two servings of fermented foods daily
If nausea, diarrhea, or vomiting are severe or persistent, your healthcare provider may recommend a dose adjustment or another strategy
CVOTs cardiovascular outcome trials, T2DM type 2 diabetes mellitus, GLP-1RAs GLP-1 receptor agonists, HbA1c glycated hemoglobin, ACS acute coronary syndrome, OAD oral antidiabetic drugs, eGFR estimated glomerular filtration rate, UACR urine albumin-creatinine ratio, CVD cardiovascular disease, BMI body mass index, T1DM type 1 diabetes mellitus, DPP-4i DPP-4 inhibitor, HR hazard ratio, CI confidence interval, HF heart failure Outside of those major clinical trials, a nationwide retrospective study in Taiwan, China, evaluated the effects of DPP-4i in elderly patients with T2DM relative to cardiovascular outcomes
When the GLP-1 tablets like Orforglipron and Oral Wegovy are released in the Uk, this will become even more affordable and we will see the percentage jump so fast
